Package Leaflet: Information for the User
Normopil 50 mg/ml Cutaneous Solution
minoxidil
Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor, pharmacist, or nurse.
Package Leaflet Contents
Normopil contains minoxidil as the active ingredient and is a solution for use on the scalp skin that stimulates hair growth in individuals with androgenetic alopecia (the most common type of baldness) when applied topically.
This medication is indicated for the treatment of moderate hair loss of androgenetic origin in adults.
Do not use Normopil
If you are allergic to minoxidil or any of the other components of this medication (listed in section 6).
Warnings and Precautions
Consult your doctor or pharmacist before starting to use Normopil:
There have been reports of excessive body hair growth in infants after skin contact with the application areas of minoxidil in patients (caregivers) using topical minoxidil. Hair growth normalized within months when infants were no longer exposed to minoxidil. Precautions should be taken to ensure that children do not come into contact with the areas of the body where minoxidil has been applied topically.
Consult your doctor if you observe excessive hair growth on your child's body during the period when using topical minoxidil products.
Children and Adolescents
This medication is not recommended for use in children or adolescents, as no studies have been conducted in this population.
Before starting treatment with Normopil, it will be necessary for your doctor to perform a complete clinical examination.
Other Medications and Normopil
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
The concomitant administration of Normopil with peripheral vasodilators (medications for the treatment of cerebrovascular disorders) and medications for the treatment of blood pressure may cause a sudden drop in blood pressure. Similarly, it should not be applied at the same time as other topical products such as tretinoin, anthralin, or betamethasone dipropionate, as they may alter the amount of minoxidil that reaches the blood.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Treatment with Normopil is not recommended if you are pregnant or breastfeeding.
Driving and Using Machines
It is unlikely to produce any effect.
Normopil contains propylene glycol (E 1520) and ethanol
This medication contains 500 mg of propylene glycol in each milliliter.
Propylene glycol may cause skin irritation.
Do not use on open wounds or large areas of damaged skin (such as burns) without consulting your doctor or pharmacist first.
This medication contains 255 mg of alcohol (96% ethanol) in each milliliter.
It may cause a burning sensation on damaged skin.
In newborns (premature and full-term babies), high concentrations of ethanol can cause severe local reactions and systemic toxicity due to significant absorption through immature skin (especially in cases of occlusion).
Products containing ethanol, which is a flammable substance, should not be used near an open flame, a lit cigarette, or certain devices (e.g., hair dryers).
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
The recommended dose is 2 ml per day. It should be applied twice a day, 1 ml in the morning and 1 ml at night.
Instructions for use:
The instructions for use depend on the type of applicator used.
Wash your hands before application.
The hair and scalp must be completely dry when applying the product.
It is recommended to use it for largeareas of the scalp.
Figure 1 Figure 2 Figure 3 Figure 4
It is recommended to use this applicator for smallareas of the scalp.
Figure 1 Figure 2 Figure 3 Figure 4 Figure 5
As with other medications, the degree of response to treatment depends on each patient, so a treatment period of 4 months may be necessary before hair growth begins.
The recommended daily dose should be respected, regardless of the extent of the alopecia. Do not increase the dose or frequency of application.
Your doctor or pharmacist will indicate the duration of your treatment with Normopil. Do not discontinue treatment prematurely, as there are data indicating that if you discontinue treatment for 3-4 months, you may return to the initial state of alopecia you had before starting treatment.
Use in People Over 65 Years
The use of Normopil is not recommended in people over 65 years, as no studies have been conducted in this population.
If you use more Normopil than you should
If you have used more Normopil than you should, consult your doctor or pharmacist immediately.
Accidental or intentional overdose after topical application of minoxidil will produce an increase in the intensity of adverse effects of a dermatological nature, especially pruritus (itching), dermatitis (redness), dryness, skin irritation, and eczema (inflammatory skin condition), usually of mild to moderate intensity and reversible upon discontinuation of treatment.
The signs and symptoms after accidental or intentional ingestion of minoxidil may include, among others, hypotension (low blood pressure), tachycardia (rapid heart rate), edema (swelling, excessive fluid accumulation), and congestive heart failure (heart failure).
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or go to a medical center, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to use Normopil
Do not use a double dose to make up for forgotten doses.
In the initial treatment period:
In the maintenance period:
If you interrupt treatment with Normopil
Discontinuing treatment for 3-4 months may cause you to return to the initial state of alopecia prior to treatment.
If you experience any of the described symptoms, consult your doctor or pharmacist.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Immediately contact a doctor if you notice any of the following symptoms, as you may require urgent medical treatment:
The most frequently reported side effects are pruritus (itching), dermatitis (redness), dryness, skin irritation, eczema (inflammatory skin condition), hypertrichosis (hair growth on the skin), usually of mild to moderate intensity and reversible upon discontinuation of treatment.
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very Rare(may affect up to 1 in 10,000 people):
Frequency Not Known(cannot be estimated from available data):
Reporting Side Effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date shown on the package label, after EXP. The expiration date is the last day of the month indicated.
The solution may take on a slightly yellowish color. The color change does not affect its effectiveness.
After the first opening of the bottle, the validity period of the medication is 40 days.
Medications should not be thrown away through wastewater or household waste. Deposit the packages and medications you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packages and medications you no longer need. This will help protect the environment.
Composition of Normopil 50 mg/ml Cutaneous Solution
Appearance of the Product and Package Contents
The solution is transparent, colorless, or slightly yellowish.
Package containing 1 bottle of 90 ml, 2 bottles of 90 ml, or 3 bottles of 90 ml of solution, and a plastic bag containing a dosing syringe and a dosing pump (one milliliter is equivalent to 5 sprays).
Marketing Authorization Holder and Manufacturer
LABORATORIOS NORMON S.A.
Ronda de Valdecarrizo, 6 - 28760 Tres Cantos - Madrid (SPAIN)
Date of the Last Revision of this Package Leaflet:September 2024
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es